GT
OCRX

Glenmede Trust’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Glenmede Trust’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,200
Closed -$32K – 2901
2017
Q3 		$32K Hold
28,200
– – ﹤0.01% 1815
2017
Q2 		$36K Hold
28,200
– – ﹤0.01% 1724
2017
Q1 		$36K Hold
28,200
– – ﹤0.01% 1724
2016
Q4 		$59K Buy
28,200
+16,848
+148% +$39.3K ﹤0.01% 1565
2016
Q3 		$29K Hold
11,352
– – ﹤0.01% 1821
2016
Q2 		$21K Hold
11,352
– – ﹤0.01% 1886
2016
Q1 		$33K Hold
11,352
– – ﹤0.01% 1661
2015
Q4 		$35K Hold
11,352
– – ﹤0.01% 1689
2015
Q3 		$35K Hold
11,352
– – ﹤0.01% 1711
2015
Q2 		$43K Hold
11,352
– – ﹤0.01% 1687
2015
Q1 		$53K Hold
11,352
– – ﹤0.01% 1662
2014
Q4 		$72K Hold
11,352
– – ﹤0.01% 1644
2014
Q3 		$55K Hold
11,352
– – ﹤0.01% 1664
2014
Q2 		$86K Hold
11,352
– – ﹤0.01% 1465
2014
Q1 		$119K Buy
+11,352
New +$162K ﹤0.01% 1353

Glenmede Trust's OCRX Position: Q4 2017 in Review

Glenmede Trust sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 28,200 shares — an estimated $32K sold.

Glenmede Trust first reported a position in OCRX in Q1 2014 and held it in 15 quarters. The position peaked at $119K in Q1 2014. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

  • Glenmede Trust reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Glenmede Trust sold 28,200 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $32K.
  • Glenmede Trust first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 15 quarters.
  • Glenmede Trust's Ocera Therapeutics, Inc. position peaked at $119K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on Glenmede Trust's 13F filing for Q4 2017, filed 15 Feb 2018.